Delivery Order SPE2DB25D3201-SPE2DB25FNTGQ
Award Date
5/20/25
Potential Completion Date
6/11/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Ingrezza 80 mg capsules. The contract has a ceiling value of $3,893.15 and a period of performance through June 6, 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,352.24 delivery order contract is for the supply of Ingrezza 40 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and an ultimate completion date of May 28, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,676.12, is for the delivery of the pharmaceutical product Ingrezza 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm-fixed-price delivery order is for the medication Ingrezza 40 mg capsules. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,119.55 firm-fixed-price contract is for the delivery of Ingrezza 40 mg capsules, a specialty medication, to support military healthcare programs. The contract has a completion date of June 21, 2023 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Ingrezza 40 mg capsules. The $3,119.55 firm fixed-price delivery order has an ultimate completion date of April 10, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for the supply of Ingrezza 40 mg capsules. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,893.15, is for the delivery of Ingrezza 80 mg capsules. The contract has an ultimate completion date of July 25, 2024 and was awarded on July 3, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for the supply of 4,568,061,451 units of the 80 mg capsule of the drug Ingrezza. The contract has a performance period extending through May 19, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...